Project Grant R41AG074835
- This Project Grant award of $353,391.00, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate the use of a "Personal Learning Curve" paradigm as a sensitive marker of early memory decline related to Alzheimer's disease (AD) biomarkers in a large, diverse sample of older adults. The study seeks to determine if this digital cognitive assessment tool, which measures learning over repeated evaluations, can detect subtle AD-related memory failures...
- Grant Summary: Activities4Care Digital Platform Plans4Care Inc. received a $490,262 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded on June 15, 2025, with completion targeted for May 31, 2026. The award funds development and testing of Activities4Care, a digital platform designed to address the critical unmet need for meaningful activities among the 6+ million individuals living with Alzheimer's disease and Alzheimer's disease-related...
- The National Institute on Aging awarded $431,990 to the Brain Research Africa Initiative under the Aging Research program (CFDA 93.866) for a two-year project period (February 1, 2026 – January 31, 2028) to develop and validate tablet-based cognitive assessment tools for dementia screening in Cameroon. The primary deliverables include cultural adaptation and validation of a brief multi-domain digital cognitive assessment tool tailored to diverse Cameroonian populations, along with development of...
- Federal Project Grant Award Summary Viewmind Inc. received a $495,731 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) to evaluate its proprietary digital diagnostic technology for detecting Alzheimer's disease biomarkers in individuals with mild cognitive impairment (MCI). The award, issued September 20, 2025, with completion targeted for September 19, 2026, funds research to validate Viewmind's ocular digital phenotyping platform—which...
- Federal Project Grant Award Summary S-3 Research LLC received a $999,556 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) effective September 20, 2025, with a completion date of September 19, 2026. The award funds the development of a multi-modal digital tool designed to improve diversity and inclusivity in Alzheimer's Disease and Related Dementias (ADRD) clinical trial participation. The deliverables include a mobile application, website...
- This Project Grant award of $4,787,820.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a better understanding of the individual- and system-level characteristics that influence diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), and how diagnosis can moderate the effects of cognitive decline on employment, future care, and quality of life. The key objectives are to: 1) examine whether older adults experiencing...
- Project Grant Award Summary The National Institute on Aging awarded University of California, Davis a $3.42 million Project Grant (CFDA 93.866, Aging Research) on September 15, 2025, to develop and validate digital biomarkers capturing the dynamic relationship between social and cognitive health as early indicators of Alzheimer's disease and related dementias (AD/ADRD). Over the four-year project period through September 2029, the research team will address three critical gaps in understanding...
- Federal Grant Award Summary Boston University Medical Campus received a $327,000 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded September 5, 2025, with completion scheduled for August 31, 2027. The grant supports research exploring heterogeneity of cognitive trajectories in preclinical Alzheimer's disease through digital phenotyping methodologies. The project leverages multimodal data integration, combining traditional...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $336,000 Project Grant award from the National Institute on Aging (Aging Research program, CFDA 93.866) effective September 1, 2025, through August 31, 2027. The award supports research evaluating subjective cognitive concerns (SCC) as an early screening tool for Alzheimer's disease (AD) by assessing their relationship with longitudinal AD biomarkers. The research will be conducted within the Einstein Aging Study,...
- Federal Cooperative Agreement Summary The National Institute on Aging (part of the National Institutes of Health) awarded a Cooperative Agreement totaling $3.49 million to The Pennsylvania State University on April 15, 2026, under the Aging Research program (CFDA 93.866). The award supports the development and implementation of the Mobile Monitoring of Cognitive Change (M2C2) platform—an open-source, scalable mobile-first system designed to detect subtle cognitive changes associated with...
DEVELOPMENT OF A DIGITAL COGNITIVE SCREENING TEST TO DETECT MILD COGNITIVE IMPAIRMENT AND DEMENTIA IN CLINICAL SETTINGS. - PROJECT SUMMARY ALZHEIMER'S DISEASE AND RELATED DEMENTIAS ARE A GROWING HEALTH PROBLEM IN OUR AGING POPULATION. ASSESSMENT OF COGNITIVE FUNCTIONING FOR EARLY DETECTION IS CRITICAL TO IDENTIFY INDIVIDUALS WHO MIGHT BENEFIT FROM TREATMENT WITH THE AVAILABLE SYMPTOMATIC MEDICATIONS FOR MILD DEMENTIA AS WELL AS FUTURE DISEASE-MODIFYING THERAPIES THAT ARE ACTIVELY UNDER DEVELOPMENT AND BEING TESTED IN CLINICAL RESEARCH TRIALS. CURRENT COGNITIVE SCREENING TOOLS ARE TIME-CONSUMING AND NOT ROUTINELY USED OR DOCUMENTED IN BUSY PRIMARY CARE SETTINGS. AS A RESULT, WE NEED EASILY ACCESSIBLE TOOLS, SUCH AS PATIENT SELF-ADMINISTERED MEASURES, TO SCREEN INDIVIDUALS IN PRIMARY CARE SETTINGS TO GUIDE COUNSELING, REFERRALS, AND INTERVENTIONS. THE PROPOSED STTR PHASE I PROJECT AIMS TO DEVELOP AND TEST AN INNOVATIVE DIGITAL COGNITIVE SCREENING INSTRUMENT, RIMCAT (RHODE ISLAND MOBILE COGNITIVE ASSESSMENT TOOL) TO IDENTIFY MILD COGNITIVE IMPAIRMENT AND DEMENTIA IN OLDER ADULTS. RIMCAT CONSISTS OF 10 COMPONENTS AND WAS DESIGNED FOR SELF-ADMINISTRATION IN SUPERVISED SETTINGS SUCH AS PRIMARY CARE PRACTICES AND PROVIDES A COGNITIVE-FRIENDLY INTERFACE ALLOWING VOICE INPUTS, KEYBOARD TYPING, AND EASY-TO-UNDERSTAND INSTRUCTIONS. THE GOAL OF THIS STTR PROJECT IS TO EXAMINE THE INITIAL RELIABILITY AND VALIDITY OF RIMCAT THROUGH A PSYCHOMETRIC STUDY. THE PROJECT ALSO INCLUDES THE DEVELOPMENT OF A DIGITAL HEALTH FRAMEWORK TO SUPPORT THE WORKFLOW OF MCI/DEMENTIA SCREENING. THIS WORK WILL ESTABLISH THE USABILITY OF RIMCAT AMONG OLDER ADULTS WHO COULD UNDERGO THE SCREENING ASSESSMENT ON A DIGITAL PLATFORM, REGARDLESS OF THEIR ABILITY TO USE MODERN MOBILE TECHNOLOGIES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 2/22/24 | ||
| Not listed | $205.2k | 8/1/22 | ||
| Not listed | $205.2k | 8/1/22 | ||
| Not listed | $0 | 7/28/22 | ||
| Not listed | $0 | 7/28/22 |